HomeRX • CVE
add
Biosyent Inc
Previous close
$10.25
Day range
$10.29 - $10.56
Year range
$8.24 - $12.13
Market cap
120.45M CAD
Avg Volume
4.65K
P/E ratio
17.05
Dividend yield
1.90%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 8.80M | 6.32% |
Operating expense | 4.72M | -8.80% |
Net income | 1.61M | 11.19% |
Net profit margin | 18.34 | 4.56% |
Earnings per share | — | — |
EBITDA | 2.62M | 62.65% |
Effective tax rate | 28.33% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.94M | -39.13% |
Total assets | 41.36M | -0.41% |
Total liabilities | 6.36M | -6.10% |
Total equity | 35.00M | — |
Shares outstanding | 11.26M | — |
Price to book | 3.31 | — |
Return on assets | 14.02% | — |
Return on capital | 16.35% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.61M | 11.19% |
Cash from operations | 2.62M | 287.80% |
Cash from investing | 882.82K | 196.33% |
Cash from financing | -4.20M | -226.21% |
Net change in cash | -668.07K | 60.26% |
Free cash flow | 2.29M | 268.87% |
About
Founded
1947
Headquarters
Website
